ArticleMedicine2019

Rationale and design to assess the efficacy and safety of HT047 in patients with acute ischemic stroke: A multicenter, randomized, double-blind, placebo-controlled, parallel-group, phase II trial.

Sung Hyuk Heo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.